ARDELYX, INC. Tax Withholding Paid on Stock Awards
ARDELYX, INC. (ARDX) reported Tax Withholding Paid on Stock Awards of $0 for the 12-month period ending 2023-12-31, per its 10-K filed 2024-02-22.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation · last filed 2024-02-22
- ARDELYX, INC. payment, tax withholding, share-based payment arrangement for the quarter ending 2022-12-31 was $0.00.
- ARDELYX, INC. payment, tax withholding, share-based payment arrangement for the quarter ending 2021-12-31 was $0.00.
- ARDELYX, INC. payment, tax withholding, share-based payment arrangement for the quarter ending 2020-12-31 was $0.00.
- ARDELYX, INC. payment, tax withholding, share-based payment arrangement for fiscal 2023 was $0.00.
- ARDELYX, INC. payment, tax withholding, share-based payment arrangement for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
- ARDELYX, INC. payment, tax withholding, share-based payment arrangement for fiscal 2021 was $106.00K.
- ARDELYX, INC. payment, tax withholding, share-based payment arrangement for fiscal 2020 was $0.00.
| Period end | Payment, Tax Withholding, Share-based Payment Arrangement 3 month | Payment, Tax Withholding, Share-based Payment Arrangement 9 month | Payment, Tax Withholding, Share-based Payment Arrangement 12 month |
|---|---|---|---|
| 2023-12-31 | $0.00 10-K · filed 2024-02-22 | ||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $0.00 10-K · filed 2024-02-22 | |
| 2022-09-30 | $0.00 10-Q · filed 2022-11-03 | ||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $106.00K 10-K · filed 2024-02-22 | |
| 2021-09-30 | $106.00K 10-Q · filed 2022-11-03 | ||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | $0.00 10-K · filed 2023-03-02 | |
| 2020-09-30 | $0.00 10-Q · filed 2021-11-12 | ||
| 2019-12-31 | $0.00 10-K · filed 2022-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |